α-Adrenoceptors in canine mesenteric artery are predominantly 1A subtype: Pharmacological and immunochemical evidence

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 671-679

  Daniel, E E ^a,c   Brown, R Dale ^a,b   Wang, Y F ^a   Low, A M ^a   Lu Chao, H ^a   Kwan, C Y ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HINES VA HOSPITAL   (United States)

^c Health Sciences Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 8 [2 [(2,3 DIHYDRO 1,4 BENZODIOXIN 2 YL)METHYLAMINO]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE MESYLATE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; 8 [3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]PROPYLCARBAMOYL] 3 METHYLFLAVONE; 8 [4 (1,4 BENZODIOXAN 2 YLMETHYLAMINO)BUTYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA ADRENERGIC RECEPTOR; PRAZOSIN; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; DOG; DRUG RECEPTOR BINDING; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR OCCUPANCY;

ANIMALS; ANTIBODIES; AORTA; COLORING AGENTS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0032722237     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bevan JA, Bevan RD and Shreeve SM (1989) Variable receptor affinity hypothesis. FASEB J 3:1696-1704.
2. 2-adrenoceptor subtype in canine saphenous vein: Comparison to mesenteric vein. Br J Pharmacol 117:1535-1543.
3. Daniel EE, Low AM, Lu-Chao H, Gaspar V and Kwan CY (1997). Characterization of α-adrenoceptors in canine mesenteric vein. J Cardiovasc Pharmacol 30:591-598.
4. Fonseca MI, Button DC and Brown RD (1995) Agonist regulation of alpha 1B-adrenergic receptor subcellular distribution and function. J Biol Chem 270:8902-8909.
5. 1-adrenoceptor classification. Br J Pharmacol 121:1127-1135.
6. 1-Adrenoceptor classification: Sharpening Occam's razor. Trends Pharmacol Sci 15:167-170.
7. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory, in Handbook of Experimental Pharmacology: New Series (Eichler O, Farah A, Herken H and Welch AD eds) pp 283-335, Springer Verlag, Berlin.
8. 1-adrenoceptors. Eur J Pharmacol 272:R5.
9. 2+ in smooth muscle. Nature (Lond) 329:333-335.
10. 1adrenergic receptors revealed by chloroethylclonidine. Mol Pharmacol 32:505-510.
11. 1-adrenoceptors: Consensus update. Pharmacol Rev 47:267-270.
12. 2-adrenoceptors. Pharmacol Commun 6:91-97.
13. 1-adrenoceptor subtypes in canine aorta using alkylating agents. Can J Physiol Pharmacol 72:97-103.
14. Leonardi A, Hieble JP, Guarneri L, Naselsky DP, Poggesi E, Sironi G, Sulpizio AC and Testa R (1997) Pharmacological characterization of the uroselective alpha-antagonist Rec 15/2739 (SB 216469): Role of the alpha-1L adrenoceptor in tissue selectivity, part 1. J Pharmacol Exp Ther 281:1272-1283.
15. Lomasney JW, Cotecchia S, Lefkowitz RJ and Caron MG (1991a) Molecular biology of α-adrenergic receptors: Implications for receptor classification and for structure-function relationships. Biochem Biophys Acta 1095:127-139.
16. 1A-adrenergic receptor. J Biol Chem 226:6365-6369.
17. Low AM, Lu-Chao H, Loke JCP, Kwan CY and Daniel EE (1999) Insights into the unusual α-adrenoceptor subtype in dog saphenous vein using phenoxybenzamine. J Pharmacol Exp Ther 288:148-156.
18. 1-adrenoceptors in dog aorta. J Pharmacol Exp Ther 286:894-901.
19. 2-adrenoceptor subtypes. Mol Pharmacol 44:1165-1170.
20. 1-adrenoceptors: Subclassification and functional aspects, in α-Adrenoceptors: Signal Transduction, Ionic Channels and Effector Organs (Fujiwara M, Sugimoto T and Kogure K eds) pp 193-202, Excerpta Medica, Toyko.
21. 1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99:197-201.
22. 1-adrenoceptor subtypes in the rat vas deferens: Binding and functional studies. Br J Pharmacol 107:697-704.
23. 1A subtype. Mol Pharmacol 48:823-831.
24. Piascik MT, Hrometz SL, Edelman SE, Guarino RD, Hadley RW and Brown RD (1997) Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: Analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 283:854-868.
25. 1 adrenoceptors are of the α1D subtype. Can J Physiol Pharmacol 72 (Suppl 1):323.
26. Saussy DL Jr, Goetz AS, Queen KL, King HK, Lutz MW and Rimele TJ (1996) Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: Further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J Pharmacol Exp Ther 278:136-144.
27. 1-adrenoceptor subtypes: Selective antagonists suggest the existence of a fourth subtype. Eur J Pharmacol 227:433-436.
28. 3H-rauwolscine binding sites. J Cardiovasc Pharmacol 15:515-526.
29. max) of alpha adrenoceptor binding sites and contractile responses in four canine vascular tissues. J Pharmacol Exp Ther 250:1119-1124.
30. 3H-rauwolscine binding to canine venous smooth muscle membranes. Can J Physiol Pharmacol 67:1067-1073.
31. Shimamoto H, Bourreau J-P, Kwan CY and Daniel EE (1992) Amplification of alpha adrenergic vasoconstriction in canine isolated mesenteric artery and vein. J Pharmacol Exp Ther 212:1119-1127.
32. Testa R, Guarneri L, Angelico P, Poggesi E, Taddei C, Sironi G, Colombo D, Sulpizio AC, Naselsky DP, Hieble JP and Leonardi A (1997) Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): Role of the alpha-1L adrenoceptor in tissue selectivity, part II. J Pharmacol Exp Ther 281: 1284-1293.
33. Testa R, Guarneri L, Taddei C, Poggesi E, Angelico P, Sartini A, Leonardi A, Gofrit ON, Meretk S and Caine M (1996) Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery. J Pharmacol Exp Ther 277:1237-1246.
34. 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery. Br J Pharmacol 118:1308-1316.
35. 1-adrenoceptor mediating vasoconstriction in perfused rat mesenteric vascular bed. Acta Pharmacol Sinica 20:151-156.